miRNAs in lung cancer - Studying complex fingerprints in patient's blood cells by microarray experiments
-
* Corresponding author: Andreas Keller andreas.keller@febit.de
- Equal contributors
1 febit biomed gmbh, Im Neuenheimer Feld 519, 69120 Heidelberg, Germany
2 Department of Human Genetics, Medical School, Saarland University, Building 60, 66421 Homburg, Germany
3 Department of Cardiothoracic Surgery, Voelklingen Heart Center, 66333 Voelklingen, Germany
4 Center for Bioinformatics, Saarland University, Building E 1 1, 66041Saarbruecken, Germany
BMC Cancer 2009, 9:353 doi:10.1186/1471-2407-9-353
Published: 6 October 2009Additional files
Additional file 1:
Table S1. Details of all miRNAs for the miRVANA screening (columns A-I), MPEA Assay (columns K-S) and the MI (columns U-V). Significant miRNAs are colored.
Format: XLS Size: 352KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 2:
Table S2. Mutual Information of biomarkers. This table contains for each miRNA biomarker the Mutual Information (MI) together with the enrichment as compared to the background MI. The miRNAs with MI higher than the highest background MI are colored red, the miRNAs with MI values higher than highest 5% background MI's in blue.
Format: XLS Size: 141KB Download file
This file can be viewed with: Microsoft Excel Viewer
